![Francois Vigneault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Francois Vigneault held the position of Chief Executive Officer at Shape Therapeutics, Inc. from 2018 to 2024.
Dr. Vigneault was the founder of Shape Therapeutics, Inc., founded in 2018, and held the title of Chief Executive Officer.
Dr. Vigneault is also the founder of AbVitro LLC..
Anciens postes connus de Francois Vigneault
| Sociétés | Poste | Fin |
|---|---|---|
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Directeur Général | 18/10/2024 |
AbVitro LLC
 AbVitro LLC BiotechnologyHealth Technology Provides an antibody discovery platform | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AbVitro LLC
AbVitro LLC BiotechnologyHealth Technology Provides an antibody discovery platform | Health Technology |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
